Skip to content

Clinical Validation of the Apollo Daily Disposable Soft Contact Lenses

Clinical Validation of the Apollo Daily Disposable Soft Contact Lenses

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05035017
Enrollment
35
Registered
2021-09-05
Start date
2021-06-17
Completion date
2021-07-31
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The purpose of this study was to confirm the design specifications of a Test lens and validate its clinical performance.

Detailed description

This was a double-masked, randomized, bilateral two-day crossover, dispensing study design. Subjects were randomized to wear the Test lens or Control lens bilaterally in random order and on a daily wear, single-use basis for a period of 2 days each.

Interventions

DEVICETest Lens

Daily disposable with modified lens design for 2 days

Daily disposable lens for 2 days

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Has had a self-reported oculo-visual examination in the last two years. * Is at least 18 years of age and has full legal capacity to volunteer. * Has read and understood the information consent letter. * Is willing and able to follow instructions and maintain the appointment schedule. * Is an adapted soft contact lens wearer, having worn contact lenses for a minimum 4 weeks prior to the study * Has spectacle cylinder ≤1.00D in both eyes. * Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes. * Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/20 in each eye. * Wears CLs in both eyes (monovision acceptable, but not monofit) * Has clear corneas and no active ocular disease. * Has not worn lenses for at least 12 hours before the examination * Is willing to wear the study contact lenses for a minimum 8 hours on at least two consecutive days for each study pair.

Exclusion criteria

* Has never worn contact lenses before. * Has any systemic disease affecting ocular health. * Is using any concomitant systemic or topical medications that will affect ocular health. * Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses. * Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye. * Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars. * Is aphakic. * Has undergone corneal refractive surgery. * Is participating in any other type of eye-related clinical or research study.

Design outcomes

Primary

MeasureTime frameDescription
Overall Comfort With Lens2 daysParticipants rated their overall comfort once after 2 days of wear a 0-100 integer scale, where 0=Cannot be tolerated and 100=Excellent comfort.

Secondary

MeasureTime frameDescription
Overall Vision Quality2 daysParticipant response measured once after 2 days of wear on a 0-100 integer scale, where 0= Unacceptable, 100=Excellent Vision.
Overall Lens Fit Acceptance2 daysMeasured once after 2 days of wear by investigator on lens fit alone (excludes comfort, vision, orientation) on a 0-4 scale, 0.25 steps, where 0=Can't be worn and 4=Optimum
Overall Lens Handling2 daysParticipant response on overall handling (insertion, removal, and holding) of contact lenses assessed once after 2 days of wear, on the third day. Measured on a 0-100 integer scale, where 0=Cannot be managed, 100=Excellent handling.
Anterior Ocular Health - Corneal Staining Extent2 daysAssessed once after 2 days of wear with slit lamp biomicroscopy and graded on a 0-4 integer scale, where 0=No Staining and 4=\>45% of area. Lower values represented a better outcome, e.g., a grading value of 1 would represent less corneal staining than a grade of 4. Locations (central, nasal, temporal, superior, inferior) were graded separately.

Countries

United States

Participant flow

Participants by arm

ArmCount
Overall Study
All participants who were dispensed lenses and successfully completed the study
35
Total35

Baseline characteristics

CharacteristicOverall Study
Age, Continuous25.4 years
STANDARD_DEVIATION 4.2
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
27 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 350 / 35
other
Total, other adverse events
0 / 350 / 35
serious
Total, serious adverse events
0 / 350 / 35

Outcome results

Primary

Overall Comfort With Lens

Participants rated their overall comfort once after 2 days of wear a 0-100 integer scale, where 0=Cannot be tolerated and 100=Excellent comfort.

Time frame: 2 days

ArmMeasureValue (MEAN)Dispersion
Test LensOverall Comfort With Lens86 score on a scaleStandard Deviation 15
Control LensOverall Comfort With Lens72 score on a scaleStandard Deviation 26
Secondary

Anterior Ocular Health - Corneal Staining Extent

Assessed once after 2 days of wear with slit lamp biomicroscopy and graded on a 0-4 integer scale, where 0=No Staining and 4=\>45% of area. Lower values represented a better outcome, e.g., a grading value of 1 would represent less corneal staining than a grade of 4. Locations (central, nasal, temporal, superior, inferior) were graded separately.

Time frame: 2 days

ArmMeasureGroupValue (MEAN)Dispersion
Test LensAnterior Ocular Health - Corneal Staining ExtentNasal0.11 score on a scaleStandard Deviation 0.32
Test LensAnterior Ocular Health - Corneal Staining ExtentSuperior0.04 score on a scaleStandard Deviation 0.2
Test LensAnterior Ocular Health - Corneal Staining ExtentTemporal0.10 score on a scaleStandard Deviation 0.3
Test LensAnterior Ocular Health - Corneal Staining ExtentInferior0.39 score on a scaleStandard Deviation 0.52
Test LensAnterior Ocular Health - Corneal Staining ExtentCentral0.10 score on a scaleStandard Deviation 0.3
Control LensAnterior Ocular Health - Corneal Staining ExtentInferior0.41 score on a scaleStandard Deviation 0.55
Control LensAnterior Ocular Health - Corneal Staining ExtentCentral0.16 score on a scaleStandard Deviation 0.44
Control LensAnterior Ocular Health - Corneal Staining ExtentNasal0.14 score on a scaleStandard Deviation 0.39
Control LensAnterior Ocular Health - Corneal Staining ExtentTemporal0.13 score on a scaleStandard Deviation 0.34
Control LensAnterior Ocular Health - Corneal Staining ExtentSuperior0.06 score on a scaleStandard Deviation 0.23
Secondary

Overall Lens Fit Acceptance

Measured once after 2 days of wear by investigator on lens fit alone (excludes comfort, vision, orientation) on a 0-4 scale, 0.25 steps, where 0=Can't be worn and 4=Optimum

Time frame: 2 days

ArmMeasureValue (MEAN)Dispersion
Test LensOverall Lens Fit Acceptance3.11 score on a scaleStandard Deviation 0.66
Control LensOverall Lens Fit Acceptance3.09 score on a scaleStandard Deviation 0.7
Secondary

Overall Lens Handling

Participant response on overall handling (insertion, removal, and holding) of contact lenses assessed once after 2 days of wear, on the third day. Measured on a 0-100 integer scale, where 0=Cannot be managed, 100=Excellent handling.

Time frame: 2 days

ArmMeasureValue (MEAN)Dispersion
Test LensOverall Lens Handling88 score on a scaleStandard Deviation 15
Control LensOverall Lens Handling87 score on a scaleStandard Deviation 14
Secondary

Overall Vision Quality

Participant response measured once after 2 days of wear on a 0-100 integer scale, where 0= Unacceptable, 100=Excellent Vision.

Time frame: 2 days

ArmMeasureValue (MEAN)Dispersion
Test LensOverall Vision Quality90 score on a scaleStandard Deviation 11
Control LensOverall Vision Quality91 score on a scaleStandard Deviation 11

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026